-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Reprinted from: Xinhua News Agency Xinhuanet Compiled: CrystalOn the afternoon of May 29, Shanghai held a press conferen.
Wu Qing, member of the Standing Committee of the Shanghai Municipal Party Committee and executive vice mayor, said at the press conference that resumption of work and production and resumption of business and market are issues of great concern to various enterprises at prese.
In view of the blocking points of resumption of work and production, classified guidance, dynamic revision of the epidemic prevention and control guidelines for resumption of work and production, andcancellation of unreasonable restrictions on resumption of work and production and resumption of the market (the whitelist system for resumption of work and production will be cancelled from June 1s.
), expand the scope of subsidies for enterprise epidemic prevention and sterilization, establish and improve the mutual protection mechanism of the Yangtze River Delta industrial chain and supply chain, smooth domestic and international logistics and transportation channels and other policy measures, fully support and organize the promotion of enterprises in various industries to resume work and production and resume the market, and steadily improve business recovery ra.
Shanghai will support automobile, integrated circuit, biopharmaceutical and other manufacturing enterprises to lead the chain from point to point, realize the coordinated resumption of work of upstream and downstream enterprises in the industrial chain and supply chain, and steadily improve the production rate of enterpris.
In Shanghai, the highland of the biopharmaceutical industry, many companies did their best to "escort" life and health during the epidem.
Boehringer Ingelheim 's production capacity is about 70%: "Through closed-loop management, our production has never stoppe.
" said Wang Yihua, director of technical operations at Shanghai Boehringer Ingelheim Pharmaceutical .
, L.
, a multinational pharmaceutical company located in Zhangjiang, Shangh.
The production capacity is about 70% of the previous one, and 100% of the products produced can be delivered to customer.
As the epidemic prevention and control situation improves, we have brought the second batch of employees back to the factory area, and the follow-up production capacity will continue to increas.
” Ringer Ingelheim's experience of resuming work and production is a microcosm of Shanghai's biomedical war against the "epidemic.
Biomedicine is one of the three major leading industries in Shangha.
Since the epidemic, quite a number of Shanghai biopharmaceutical companies have implemented closed-loop production, making every effort to ensure the production and supply of anti-tumor and other major disease drugs and device.
Fosun Kite Biotech's production capacity has recovered to 70%: Among anti-tumor drugs, the production and transportation of CAR-T (Chimeric Antigen Receptor T-cell Immunotherapy) drugs has attracted much attentio.
CAR-T drugs have a good effect on some hematological tumors, but their production process and quality control standards are very strict, especially the transportation must be carried out under the conditions of the whole cold chai.
The akirenxe injection developed by Fosun Kite Biotechnology .
, L.
is the first CAR-T drug approved in Chin.
Huang Hai, CEO of Fosun Kite, said that since March 16, the company's production base has implemented closed production, and more than 50 employees are on the production line to ensure the continuous supply of CAR-T drug.
After the company entered the "white list" for resumption of work and production in April, more than 80 employees returned to wor.
At present, the company's production capacity has returned to about 70% of the pre-epidemic leve.
For more than two months, Fosun Kite has completed the personalized production of dozens of CAR-T drugs under the epidemic, and delivered them to patients in Beijing, Chengdu, Guangzhou and other plac.
Shanghai Desano Chemical and Pharmaceutical production capacity has recovered to 80%: As a key enterprise in the "white list" of Shanghai's resumption of work and production, Shanghai Desano Chemical and Pharmaceutical .
, L.
currently has more than 600 employees on duty, and the production capacity has returned to normal leve.
About eighty percen.
Desano is an important supplier of raw materials for anti-AIDS drugs in the worl.
"On April 18, we recalled the first batch of more than 300 employees from the prevention area to participate in closed-loop production, and then recalled them in batch.
At present, there are more than 600 employee.
It can be said that the situation is getting better day by da.
" Diesel Ye Shi, general manager of Nuo sai.
72 workers from Shanghai Roche have returned to work: The anti-tumor drug "Xeloda" of Roche, a multinational pharmaceutical company, was in short supply and was about to face out of stock in many regions of the countr.
After being included in the first batch of "white list" for the resumption of work and production of key enterprises, 72 resumed workers of all types of work required for the production of "Xeloda" by Shanghai Roche Pharmaceutical .
, L.
have arrive.
At the same time, the first batch of inter-provincial passes were successfully approved, which also "escorted" the cold chain transportation of drug.
During the epidemic, in addition to laboratory research, clinical trials of new drugs are also a key part of the development of the biopharmaceutical industr.
Laikai Pharmaceutical Technology Completes Global Multi-Center Clinical Trial of Breast Cancer : The reporter learned from Laikai Pharmaceutical Technology (Shanghai) .
, L.
that in May this year, researchers overcame various difficulties and simultaneously completed a breast cancer clinical trial in China and the United Stat.
Global multicenter clinical trial.
Bodong Medical Technology .
, L.
has carried out several large-scale clinical trials:Bodong Medical Technology .
, L.
, which focuses on the field of precise diagnosis of pan-vascular intervention, has carried out a number of large-scale clinical trials at home and abroad in an orderly manner during the epidemic, preparing for the subsequent introduction of Chinese technology abro.
Biomedical cloud signing and cloud docking: With the gradual improvement of the epidemic situation, Shanghai has recently promoted the settlement of industrial projects through "cloud signing" and "cloud docking", and biomedicine has become one of the protagonis.
Pudong New Area, a highland of biomedical development, recently released the "2022 Pudong New Area Science and Technology Development Fund Industry-University-Research Special (Biomedicine) Application Guide" to further increase support for clinical research on epidemic prevention-related products, innovative drugs and innovative medical devic.
100% full-load production of Shanghai Siemens Medical Devices : In the production workshop of Shanghai Siemens Medical Devices .
, L.
, which has achieved 100% full-load production, more than 400 employees are engaged in closed-loop producti.
Kong Jun, senior vice president and general manager of the company, said that "Made in Shanghai" can not only meet the needs of domestic and foreign markets, but also ensure the orderly operation of the global supply cha.
With the promulgation of the "Shanghai Action Plan for Accelerating Economic Recovery and Revitalization" on May 29 , more employees will return to work, logistics will be smoother, and the biopharmaceutical industry will continue to recove.
Source: Shanghai Municipal People's Government website
Since June 1, the whitelist system for resumption of work and production will be abolishe.Wu Qing, member of the Standing Committee of the Shanghai Municipal Party Committee and executive vice mayor, said at the press conference that resumption of work and production and resumption of business and market are issues of great concern to various enterprises at prese.
In view of the blocking points of resumption of work and production, classified guidance, dynamic revision of the epidemic prevention and control guidelines for resumption of work and production, andcancellation of unreasonable restrictions on resumption of work and production and resumption of the market (the whitelist system for resumption of work and production will be cancelled from June 1s.
), expand the scope of subsidies for enterprise epidemic prevention and sterilization, establish and improve the mutual protection mechanism of the Yangtze River Delta industrial chain and supply chain, smooth domestic and international logistics and transportation channels and other policy measures, fully support and organize the promotion of enterprises in various industries to resume work and production and resume the market, and steadily improve business recovery ra.
Shanghai will support automobile, integrated circuit, biopharmaceutical and other manufacturing enterprises to lead the chain from point to point, realize the coordinated resumption of work of upstream and downstream enterprises in the industrial chain and supply chain, and steadily improve the production rate of enterpris.
Shanghai: Resurrection of the biopharmaceutical industry
Production does not stop and research and development does not st.In Shanghai, the highland of the biopharmaceutical industry, many companies did their best to "escort" life and health during the epidem.
Boehringer Ingelheim 's production capacity is about 70%: "Through closed-loop management, our production has never stoppe.
" said Wang Yihua, director of technical operations at Shanghai Boehringer Ingelheim Pharmaceutical .
, L.
, a multinational pharmaceutical company located in Zhangjiang, Shangh.
The production capacity is about 70% of the previous one, and 100% of the products produced can be delivered to customer.
As the epidemic prevention and control situation improves, we have brought the second batch of employees back to the factory area, and the follow-up production capacity will continue to increas.
” Ringer Ingelheim's experience of resuming work and production is a microcosm of Shanghai's biomedical war against the "epidemic.
Biomedicine is one of the three major leading industries in Shangha.
Since the epidemic, quite a number of Shanghai biopharmaceutical companies have implemented closed-loop production, making every effort to ensure the production and supply of anti-tumor and other major disease drugs and device.
Fosun Kite Biotech's production capacity has recovered to 70%: Among anti-tumor drugs, the production and transportation of CAR-T (Chimeric Antigen Receptor T-cell Immunotherapy) drugs has attracted much attentio.
CAR-T drugs have a good effect on some hematological tumors, but their production process and quality control standards are very strict, especially the transportation must be carried out under the conditions of the whole cold chai.
The akirenxe injection developed by Fosun Kite Biotechnology .
, L.
is the first CAR-T drug approved in Chin.
Huang Hai, CEO of Fosun Kite, said that since March 16, the company's production base has implemented closed production, and more than 50 employees are on the production line to ensure the continuous supply of CAR-T drug.
After the company entered the "white list" for resumption of work and production in April, more than 80 employees returned to wor.
At present, the company's production capacity has returned to about 70% of the pre-epidemic leve.
For more than two months, Fosun Kite has completed the personalized production of dozens of CAR-T drugs under the epidemic, and delivered them to patients in Beijing, Chengdu, Guangzhou and other plac.
Shanghai Desano Chemical and Pharmaceutical production capacity has recovered to 80%: As a key enterprise in the "white list" of Shanghai's resumption of work and production, Shanghai Desano Chemical and Pharmaceutical .
, L.
currently has more than 600 employees on duty, and the production capacity has returned to normal leve.
About eighty percen.
Desano is an important supplier of raw materials for anti-AIDS drugs in the worl.
"On April 18, we recalled the first batch of more than 300 employees from the prevention area to participate in closed-loop production, and then recalled them in batch.
At present, there are more than 600 employee.
It can be said that the situation is getting better day by da.
" Diesel Ye Shi, general manager of Nuo sai.
72 workers from Shanghai Roche have returned to work: The anti-tumor drug "Xeloda" of Roche, a multinational pharmaceutical company, was in short supply and was about to face out of stock in many regions of the countr.
After being included in the first batch of "white list" for the resumption of work and production of key enterprises, 72 resumed workers of all types of work required for the production of "Xeloda" by Shanghai Roche Pharmaceutical .
, L.
have arrive.
At the same time, the first batch of inter-provincial passes were successfully approved, which also "escorted" the cold chain transportation of drug.
During the epidemic, in addition to laboratory research, clinical trials of new drugs are also a key part of the development of the biopharmaceutical industr.
Laikai Pharmaceutical Technology Completes Global Multi-Center Clinical Trial of Breast Cancer : The reporter learned from Laikai Pharmaceutical Technology (Shanghai) .
, L.
that in May this year, researchers overcame various difficulties and simultaneously completed a breast cancer clinical trial in China and the United Stat.
Global multicenter clinical trial.
Bodong Medical Technology .
, L.
has carried out several large-scale clinical trials:Bodong Medical Technology .
, L.
, which focuses on the field of precise diagnosis of pan-vascular intervention, has carried out a number of large-scale clinical trials at home and abroad in an orderly manner during the epidemic, preparing for the subsequent introduction of Chinese technology abro.
Biomedical cloud signing and cloud docking: With the gradual improvement of the epidemic situation, Shanghai has recently promoted the settlement of industrial projects through "cloud signing" and "cloud docking", and biomedicine has become one of the protagonis.
Pudong New Area, a highland of biomedical development, recently released the "2022 Pudong New Area Science and Technology Development Fund Industry-University-Research Special (Biomedicine) Application Guide" to further increase support for clinical research on epidemic prevention-related products, innovative drugs and innovative medical devic.
100% full-load production of Shanghai Siemens Medical Devices : In the production workshop of Shanghai Siemens Medical Devices .
, L.
, which has achieved 100% full-load production, more than 400 employees are engaged in closed-loop producti.
Kong Jun, senior vice president and general manager of the company, said that "Made in Shanghai" can not only meet the needs of domestic and foreign markets, but also ensure the orderly operation of the global supply cha.
With the promulgation of the "Shanghai Action Plan for Accelerating Economic Recovery and Revitalization" on May 29 , more employees will return to work, logistics will be smoother, and the biopharmaceutical industry will continue to recove.
